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Abstract
Objective—To assess the amount of dental and skeletal expansion and stability following surgically
assisted rapid maxillary expansion,.
Methods—Data from 20 patients enrolled in the prospective study were collected prior to treatment,
at maximum expansion, at the removal of the expander 6 months later, prior to the second surgical
phase if there was one, and at the end of post-surgical orthodontics using P-A cephalograms and
dental casts.
Results—With SARPE the mean maximum expansion at the first molar was 7.48 ± 1.39 mm and
the mean relapse during post-surgical orthodontics was 2.22 ± 1.39 mm (30%). At the maximum,
3.49 ± 1.37 mm skeletal expansion was obtained, and this was stable, so the average net expansion
was 67% skeletal.
Conclusion—Clinicians should anticipate loss of about one-third of the transverse dental expansion
obtained with SARPE although the skeletal expansion is quite stable. The amount of post-surgical
relapse with SARPE appears quite similar to the changes in dental arch dimensions after non-surgical
rapid palatal expansion, and also quite similar to dental arch changes after segmental maxillary
osteotomy for expansion.
Although a number of reports on stability after surgically-assisted rapid palatal expansion
(SARPE) have been published, surprisingly little detailed information exists to document post-
surgical changes with this procedure, differentiating dental and skeletal outcomes. This is the
case for two reasons: most of the previous studies have used only dental casts or direct
measurements of dental arch dimensions, without the use of P-A cephalograms (ceph) so that
skeletal change could be differentiated from tooth movement,1–5 and stability often was
reported from the end of post-expansion orthodontic treatment, not from the point of maximum
expansion.1–4
More recent papers using pre- and post-expansion P-A ceph and dental casts have reported
more change than the earlier ones. In a series of 14 cases, Byloff and Mossaz observed a mean
8.7 mm expansion at the first molar, and on the average, 36% of this expansion (3.1 mm) had
relapsed on debonding.6 The skeletal expansion was 1.3 mm or 24 % of the dental expansion.
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Berger et al reported an average of 2.49 mm of skeletal expansion (52% of the dental
expansion).7 Nevertheless, two recent systematic reviews have concluded that no good
evidence exists for the amount of relapse after SARPE.8,9
The goal of this research project was to provide detailed data for both dental and skeletal
stability after SARPE, and to attempt to put the outcomes in the context of stability after non-
surgical orthopedic maxillary expansion and expansion with segmental LeFort I osteotomy.
Methods
Twenty patients between 15 and 54 years of age, participating in a prospective observational
study of SARPE outcomes that was approved by the Laval University ethical committee, had
dental casts and P-A cephalograms prior to SARPE (T1), at the completion of expansion (T2),
at removal of the expander approximately 6 months later (T3), prior to a 2nd surgical phase for
those who were planned to have one (T4), and at the end of orthodontic treatment (T5). All
had a transverse discrepancy of 5 mm or more, and were beyond the level of maturity at which
palatal expansion without surgery would be possible (age range 15–54 years).
The surgical technique, which involved essentially all bone cuts required for a LeFort I
osteotomy, included separation of the pterygoid junction and separation of the midpalatal
suture between incisors roots with a thin osteotome.10–13 At surgery, the expansion device
(Superscrew™) was activated enough to achieve a 1 to 1.5 mm separation of the maxillary
central incisors. All surgery was performed by the same surgeon.
A latency period of 7 days was observed and then patients were instructed to activate the screw
by 0.25 mm twice a day. The patients were monitored twice a week until the planned expansion
was achieved 12 to 20 days later. Brackets were bonded on the maxillary teeth 2 months after
the expansion was stopped. Active orthodontic treatment usually was initiated prior to SARPE
in the mandibular arch and 2 months after the expansion was stopped in the maxillary arch.
The expansion device was kept in place for approximately 6 months. Following no other
retention except the main arch wire was used until the end of orthodontic treatment.
The standardized PA cephs14 were digitized using Quick Ceph 2000™, and maxillary width
changes were evaluated as changes in the distance between Jugula (left and right) and changes
in the width of the nasal cavity (Figure 1). Measurements on dental casts to evaluate changes
in tooth positions were performed at each time point, using a digital caliper. Intercanine widths
were measured at the cusp tip. The inter-premolar (1st, 2nd) widths were measured in the mesial
fossa and the inter-molar (1s t, 2nd) widths were measured in the central fossa.
The width of the expansion screw was measured prior to cementation (T1). After removal of
the expander (T3), the appliance was poured into lab stone and the screw width was measured
again. The screw width was also measured on the PA ceph at T1 and T2. These measurements
were used to calculate the true enlargement factor of the cephalogram, which was 4%.
The method error was tested on dental casts and PA cephs. Every measurement on the dental
casts at T5 were repeated, and every PA ceph at T5 was retraced. Pearson correlations indicated
a coefficient of fidelity of 99.94% for the measurements on the dental casts and 99.90% for
the PA ceph. Statistical significance between baseline and post treatment data collection was
assessed by Student T tests, Wilcoxon rank tests, paired T tests, one way ANOVA and repeated
measures ANOVA.
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Changes during expansion (T1–T3), post-expansion changes (T3–T5) and net expansion (T1–
T5) are shown in Figure 2. All the changes were significantly different from zero (p <.001)
except those for the lower molar (not significant). Note that the amount of expansion at the
molars was very similar to the expansion at the first premolar (p = .95). This shows the
parallelism of the expansion of the posterior teeth.
The amount of skeletal expansion with SARPE and its stability is illustrated in Figure 3. Almost
all the relapse was dental, not skeletal. The skeletal expansion measured at both Jugula and the
nasal cavity was quite stable, and the percentage of expansion due to skeletal change increased
from 47% to 68% as dental relapse occurred. At the time of expansion, all patients were
expanded 2 mm beond the expected final position, and despite the dental replapse, none of the
patients were in posterior crossbite at the end of treatment.
Of the 20 subjects, 8 had a second stage of maxillary surgery for A–P and/or vertical
repositioning and 5 had a mandibular advancement only. There was no significant effect of
phase 2 surgery on transverse relapse.
Discussion
Comparison to other studies of SARPE
The mean expansion at the first molar observed in the SARPE group is similar to previous
studies using a comparable research design. The 30% relapse is less than the 36 % relapse
Byloff and Mossaz reported.6 Post-treatment retention is likely to be an important factor in
any study of stability.15 In this study, the expander was left in place for 6 months (5.98 ± 0.72
month) after the expansion was stopped, while Byloff and Moussaz6 left the distractor for 3
months and then used a removable retainer for 3 months. The 30% relapse is higher than that
reported by Berger et al7 and Pogrel et al.5 Both of these studies used 12 months follow-up,
not the end of orthodontic treatment, as their end point. It is considerably higher than the reports
from earlier papers that reported changes from end of treatment, not from the point of maximal
expansion.1–4
The amount of dental versus skeletal expansion observed in our SARPE patients, and in the
other studies6,7,16 using PA cephs, is larger than clinicians often expect. Immediately after
maximum expansion, about half the expansion (47%) was skeletal, as shown by widening of
the maxilla and nasal cavity, and half (53%) was dental. The skeletal expansion with SARPE
was quite stable—the relapse was almost totally due to lingual movement of the posterior teeth.
It has been recommended previously that 2 mm expansion beyond the desired result should be
done. Since a mean relapse of about 30% at the first molars can be expected, we concur that 2
mm excess expansion is indicated in SARPE patients with a typical expansion of 7–8 mm at
the 1st molar. This is needed to compensate for buccal tipping of the entire posterior segment
during expansion. Interestingly, there is no correlation between the amount of expansion and
the amount of relapse at the 1st molar (r =.01).
The width of the midline diastema at the maximum expansion point (T2) is highly correlated
with the first molar expansion (r = .69). This indicates that development of a diastema is a
predictor that adequate molar expansion is occurring.
Even when skeletal expansion is obtained, the low correlation between skeletal changes and
dental changes (r = .36) confirms that the maxillary segments often do not expand
symmetrically. Instead, some rotation occurs, with the teeth expanding more widely than than
bone above, as explained by Byloff and Mossaz6 and demonstrated by Chung and Goldman.
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17 This rotation of the maxillary segments and/or alveolar bending explains why the skeletal
change at the maximal expansion point is only 47% of the dental expansion (see Figure 3).
Because of this, the horizontal portion of the screw should be more than 3 mm away from the
palatal mucosa to avoid impingement.
It is interesting that this study did not confirm previous reports of a hinge-type expansion with
SARPE, with more expansion anteriorly than posteriorly (see Figure 2). This suggests that
changes in recent years in the surgical procedure for SARPE, which now includes surgical
release of the pterygoid junction, may allow a similar anterior and posterior expansion. The
increased rigidity of the Superscrew™ and its placement more in line with the first molars also
may have contributed to the more parallel expansion.18
Stability compared to non-surgical RPE
In prepubertal children and adolescents, loss of about one-third of the maximum expansion
across the first molars occurs after non-surgical rapid palatal expansion.15,19–23 P-A cephs
in patients with palatal implants who underwent maxillary expansion demonstrated that
approximately 50% of the expansion achieved by RPE in children was skeletal and the
remainder was dentoalveolar.24,25
Handelman et al compared expansion with non-surgical RPE in younger vs older patients, and
estimated that skeletal expansion was only 18% in their adult group compared to 56% for the
younger patients.22 Bacetti et al19 showed that only 0.9 mm of skeletal expansion is achieved
in RPE patients treated during or after the peak in skeletal maturation, while 3 mm of skeletal
expansion is obtained in a group treated before the peak of skeletal maturation. It is clear that
with RPE, the nature of expansion shifts from skeletal to dentoalveolar in mature individuals,
who are the candidates for SARPE. When changes are largely tooth movement through the
alveolar housing, it has been shown to be detrimental periodontally.1,26
Our data show a mean 3.47 mm of skeletal expansion, which is 68% of the mean dental
expansion (5.12 mm). Although the amount of relapse in dental arch widths with SARPE is
about the same as with non-surgical RPE in younger patients, there is a difference: with SARPE
the skeletal change is much more stable than with RPE.
Stability compared to segmental osteotomy
The best data for stability after transverse expansion with segmental LeFort I osteotomy
remains the 42 patients reported by Phillips et al27 in 1992. Comparison of the early papers
on SARPE stability to this data set has been the basis for recommending SARPE as a first stage
of treatment when repositioning of the maxilla in all three dimensions is planned.
Stability data for the 12 subjects in the Phillips’s study who had expansion equivalent to that
of our SARPE patients are shown in Table 1 and illustrated in Figure 4. The mean relapse
across the first molars was greater for the LeFort I group but the difference was not statistically
significant, while mean relapse across the canines was greater for the SARPE group and was
significant. The greater change at the canines for the SARPE group almost surely reflects tooth
movement generated by the finishing archwires. Rather than mean changes, Figure 4 shows
the number of patients with SARPE and LeFort I expansion with changes of specific
magnitudes across the first molars and first premolars, and the similarity of the distributions
is apparent.
Clinical Implications
These data do not support the conclusion of the early papers on SARPE that this procedure
produces more stable expansion than segmental osteotomies. Our data are quite compatible,
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however, with data from other studies of SARPE that used both P-A ceph and measurements
of dental cast, and found significant post-surgical changes.
It seems clear at this point that relapse in the amount of arch width increase produced by SARPE
is comparable to relapse with the other expansion procedures. Our data show that with SARPE,
the relapse is almost entirely dental, so that at the end of treatment there is a net skeletal
expansion of 67% of the total change. With nonsurgical expansion in growing patients, the
expectation is that 50% of the total change will be skeletal. No data from sequential P-A
cephalograms exist for LeFort I expansion.
The clinical results with our SARPE patients, none of whom were in posterior crossbite at the
end of treatment despite the dental relapse, support the routine use of 2 mm over-expansion
during treatment. In the LeFort 1 patients reported by Philips et al27, over-expansion was not
done. Given the similarity of relapse in intermolar width between the SARPE and LeFort 1
patients, it appears that routine overexpansion also should be part of the protocol for expansion
with osteotomy. With SARPE, space for alignment of crowded maxillary incisors can be
provided by maxillary expansion rather than premolar extraction, so extraction decision should
be postpone after the expander removed.
The similar stability of transverse expansion of the dental arches with SARPE and segmental
LeFort I osteotomies does provide some insight into the choice between the procedures. In our
view, when only transverse change is needed, SARPE would be the treatment of choice. When
a second phase of maxillary surgery to reposition the maxilla vertically or antero-posteriorly
is required, routinely doing a preliminary SARPE procedure to obtain better transverse stability
does not appear to be warranted.28 An exceptionally narrow maxilla that requires major
expansion across the posterior teeth may be an exception.29 Perhaps a consensus current view
would be that the decision for 2-stage vs 1-stage LeFort I surgery should be based, not on the
stability of transverse expansion, but on the risk and morbidity of 2 surgeries versus the risk
and morbidity of one-stage multi-segmented LeFort I for large expansion along with vertical
and/or A–P changes.
Conclusions
1. Skeletal expansion with SARPE is about half the total inter-molar expansion at the
maximum expansion point. From that point, dental relapse occurs but the skeletal
expansion is stable, so that at the end of treatment about two-thirds of the net
expansion is skeletal.
2. The transverse stability of SARPE is not significantly greater than segmental LeFort
I osteotomy, bringing into question the routine use of two-stage surgery as a way to
improve transverse stability in patients requiring widening and A–P or vertical
repositioning of the maxilla.
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Width measurements on P-A cephalometric radiographs used in this study. Maxillary (Mx)
width was measured between Jugula left (JL) and right (JR), with Jugula defined as the point
on the jugal process at the intersection of the outline of the maxillary tuberosity and the
zygomatic process. Nasal cavity (NC) width was measured between the left and right points
at the maximum concavity of the piriform rim.
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Changes in arch width with SARPE. All maxillary changes were statistically significantly
different from zero, the mandibular first molar change was not. Blue: changes during expansion
(T1–T3). Red: post expansion changes (T3–T5). Yellow: net expansion (T1–T5).
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Changes over time after SARPE in dental and skeletal dimensions, and in the percentage of
expansion that is skeletal. Note that almost all the relapse was dental, not skeletal. Repeated
measures ANOVA confirmed a significant relationship between amount of relapse and time
elapsed after surgery. The blue blocks line show expansion at the first molar. The diamond red
line shows the percentage of expansion that was skeletal at each time point. The X green line
denotes maxillary skeletal expansion at Jugula and the magenta triangle shows the expansion
across the nasal cavity.
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The percentage of patients with major relapse (>3 mm), moderate relapse (1–3 mm), minimal
change (−1 to 1 mm) and post-treatment expansion: A, after SARPE (1st molars: N = 20; 1st
premolars: N =16); B, after LeFort I segmental osteotomy (1st molars: N= 12; 1st premolars:
N = 9). The variation of N is explained by the fact that some patients had extraction of teeth
so the number of measurements is reduce for those teeth.
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